RENERVE LIMITED (RNV)

---

AI Coverage Rating: Active

ASX AI Signals has generated 3 signal for RNV during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest RNV Signals
30/06/2026	SELL
10/06/2026	SELL
04/06/2026	SELL
RNV Share Price
Current Price	$0.080
52 Week High	$0.175
52 Week Low:	$0.075
Trading at (% of 52 Week High)	45.71%

Business Overview

Renerve Limited (ASX: RNV) is an Australian company that specializes in advancing lithium and gold exploration projects. The company focuses on developing mineral resources to support the growing demand for battery and critical minerals. Its key projects include lithium exploration in Western Australia.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

The SELL recommendation for RENERVE LIMITED (RNV) is supported by technical indicators and market sentiment pointing towards a downward trend. However, moderate liquidity and potential sector volatility introduce some uncertainty.

Latest  RENERVE LIMITED(RNV)   News